Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NYSE - Delayed Quote USD

Solventum Corporation (SOLV)

Compare
66.26
+0.59
+(0.90%)
At close: April 17 at 4:00:02 PM EDT
66.26
0.00
(0.00%)
After hours: April 17 at 5:16:11 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
8,254,000
8,254,000
8,197,000
8,130,000
8,171,000
Cost of Revenue
3,661,000
3,661,000
3,504,000
3,435,000
3,248,000
Gross Profit
4,593,000
4,593,000
4,693,000
4,695,000
4,923,000
Operating Expense
3,557,000
3,557,000
3,001,000
3,002,000
3,044,000
Operating Income
1,036,000
1,036,000
1,692,000
1,693,000
1,879,000
Net Non Operating Interest Income Expense
-367,000
-367,000
--
--
--
Other Income Expense
-64,000
-64,000
-25,000
-1,000
3,000
Pretax Income
605,000
605,000
1,667,000
1,692,000
1,882,000
Tax Provision
127,000
127,000
321,000
349,000
422,000
Net Income Common Stockholders
479,000
479,000
1,346,000
1,343,000
1,460,000
Diluted NI Available to Com Stockholders
479,000
479,000
1,346,000
1,343,000
1,460,000
Basic EPS
0.38
2.77
7.79
7.78
8.45
Diluted EPS
0.38
2.76
7.79
7.78
8.45
Basic Average Shares
172,754.07
173,200
172,700
172,700
172,700
Diluted Average Shares
172,754.07
173,700
172,700
172,700
172,700
Total Operating Income as Reported
1,036,000
1,036,000
1,692,000
1,693,000
1,879,000
Rent Expense Supplemental
489,000
--
481,000
482,000
475,000
Total Expenses
7,218,000
7,218,000
6,505,000
6,437,000
6,292,000
Net Income from Continuing & Discontinued Operation
479,000
479,000
1,346,000
1,343,000
1,460,000
Normalized Income
479,000
479,000
1,346,000
1,343,000
1,460,000
Interest Expense
367,000
367,000
--
--
--
Net Interest Income
-367,000
-367,000
--
--
--
EBIT
972,000
972,000
1,667,000
1,692,000
1,879,000
EBITDA
1,527,000
1,527,000
2,228,000
2,270,000
2,476,000
Reconciled Cost of Revenue
3,661,000
3,661,000
3,504,000
3,435,000
3,248,000
Reconciled Depreciation
555,000
555,000
561,000
578,000
597,000
Net Income from Continuing Operation Net Minority Interest
479,000
479,000
1,346,000
1,343,000
1,460,000
Normalized EBITDA
1,527,000
1,527,000
2,228,000
2,270,000
2,476,000
Tax Rate for Calcs
0
0
0
0
0
12/31/2021 - 4/1/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BAX Baxter International Inc.
28.89
+3.85%
 
BDX Becton, Dickinson and Company
198.71
-0.84%
 
NVST Envista Holdings Corporation
15.18
+1.07%
 
XRAY DENTSPLY SIRONA Inc.
12.83
+1.42%
 
ALC Alcon Inc.
92.54
+0.53%
 
AVTR Avantor, Inc.
15.10
-0.98%
 
HOLX Hologic, Inc.
57.56
+1.88%
 
BLCO Bausch + Lomb Corporation
12.06
+1.77%
 
ALGN Align Technology, Inc.
171.41
+2.53%
 
RMD ResMed Inc.
212.91
+0.67%